BPC 157 Dramatically Improves Outcomes in Stomach Perforation and Gut Obstruction
Background
Severe stomach perforation, a life-threatening acute gastrointestinal injury, frequently leads to a debilitating general occlusion/occlusion-like syndrome. This complex condition is characterized by profound impairment of gut motility, delayed gastric emptying, and potential intestinal obstruction, significantly increasing patient morbidity and mortality. Current therapeutic approaches primarily focus on supportive care and infection control, but they often fall short in actively promoting rapid tissue regeneration and restoring physiological gut function. There remains an urgent and unmet clinical need for agents that can effectively accelerate healing and prevent or reverse the debilitating occlusion-like complications that commonly arise following severe gastric injury.